Clinical characteristics | No. of patients |
---|---|
Age years | Mean 53 ± 12 (21–74) Median 55 |
Sex | |
 Male | 123 |
 Female | 14 |
ALT (U/ml) | Mean 37 ± 30 (8–96) |
AST (U/ml) | Mean 30 ± 15 (14–197) |
TBiL (μmol/l) | Mean 15.9 ± 9.2 (6.1–48) Median 13.4 |
Child-Pugh score | |
 A | 129 |
 B | 8 |
HBsAg | |
 Positive | 114 |
 Negative | 23 |
Liver cirrhosis | |
 No | 31 |
 Yes | 106 |
ICG-R15 (%) | Mean 7.2 ± 4.0 (1–22.4) Median 6.6 |
AFP (ng/mL) | |
  ≤ 400 | 96 |
  > 400 | 41 |
Tumor diameter (cm) | Mean 5.5 ± 3.9 (1–15.7) Median 4.5 |
No. of tumor | |
 Single | 108 |
 Multiple | 29 |
Portal vein tumor thrombosis | |
 No | 109 |
 Yes | 28 |
BCLC stage | |
0 + A | 78 |
B + C | 59 |